Last reviewed · How we verify
tinidazole, metronidazole
At a glance
| Generic name | tinidazole, metronidazole |
|---|---|
| Also known as | Tindamax, Flagyl |
| Sponsor | University of Alabama at Birmingham |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD Surgery (NA)
- Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis (NA)
- Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection (NA)
- Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection (NA)
- Treatment of Giardia Lamblia Infections in Children (PHASE4)
- Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection (PHASE4)
- Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection (PHASE4)
- Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tinidazole, metronidazole CI brief — competitive landscape report
- tinidazole, metronidazole updates RSS · CI watch RSS
- University of Alabama at Birmingham portfolio CI